MGT Inc. Login  |  Register  |  Newsletter Subscription  |  Cart 
MGT Inc.
MGT Inc.
MGT Inc.
     

Products


Vectors Vectors
OliGlo OliGloTM Nucleic Acid Labeling Kits
Enzyme Substrates and Kits Enzyme Substrates and Kits
Enzyme Inhibitors Enzyme Inhibitors
MGT Detection Kits MGT Detection Kits
Cell Regulatory Substrates Cell Regulatory Substrates
Special Labeling Reagents Special Labeling Reagents
Lipids Lipids
Carbohydrates/Oligosaccharides Carbohydrates/Oligosaccharides  
Fluorescent Reagents Fluorescent Reagents
M1194 - 2', 7'-Dichlorofluorescein di-β-D-galactopyranoside (DCFDG)
(Dichlorofluorescein di-Galactoside, DCFDG)


Molecular Weight: 725.48

Storage: F, D, L

[C=Cold D=Desiccated F=Frozen L=Light Sensitive RT=Room Temperature]

Soluble: DMSO, DMF, sl. H2O

Absorption: (in nm) 495

Extinction (103): 529

Molecular Formula: C32H30Cl2O15

CAS Number: [N/A]

Alternative Name: Dichlorofluorescein di-Galactoside, DCFDG

Unit Price (USD): 25 mg $83.74

Bulk Price/unit (when you buy 5 or more): $66.99

Description:
Highly sensitive fluorescent substrate for measuring galactosidase and galactocerebrosidase activity inside of live cells and lysosomes.

Note:
High Purity Grade (>99%). Absorption and Emission were measured when product released fluorophore

Application:
This substrate releases the highly fluorescent fluorophore 2',7'-dichlorofluorescein (EX: 495nm / EM: 529 nm) at the site of galactosidase or galactocerebrosidase activity. Since the pKa of the released fluorophore is significantly lower than comparable fluorophores, it can retain appreciably more fluorescence in the highly acidic environment of the lysosome than other similar fluorophores. Note: Absorption prior to enzyme hydrolysis is 290 nm; 4.7K).

References:

  • van Es H.H., Veldwijk M., Havenga M., Valerio D. (1997) "A flow cytometric assay for lysosomal glucocerebrosidase" Anal. Biochem. 247: 268-271.
  • Chan KW., Waire J., Simons B., (2004) "Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay." Anal. Biochem. 334(2): 227-33.
  • Rudensky B., Paz E., Altarescu G., (2003) "Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease." Blood Cells Mol. Dis. 30(1): 97-9.
  • Daniels L.B., Glew R.H., Diven W.F., Lee R.E., Radin N.S., (1981) "An improved fluorimetric leukocyte b-glucosidase assay for Gauchers disease." Clin. Chim. Acta 115: 369-375.
  • Kaxpova E.A., Voznyi Ya V., Dudukina T.V., Tsvetkova I.V., (1991) "4-Trifluoromethylumbelliferyl glycosides as new substrates for revealing diseases connected with hereditary deficiency of lysosome glycosidases." Biochem. Int. 24: 1135-1144.

  • ©2012 Marker Gene Technologies, Inc. Published by Marker Gene Technologies, Inc., The University of Oregon Riverfront Research Park, 1850 Millrace Drive, Eugene, Oregon 97403-1992 USA. All rights reserved. For information on the use or copying of the material contained in this document, please contact us at techservice@markergene.com.